Antibiotic - EV-035

Source SynBio Database
Organization Emergent Biosolutions, Inc.
Market status Under Development
Industry Health
Value chain stage Finished Product
Intended consumer Government
Production process Closed Production
Business models B2C
Product categories Medical Treatment
Biotech components Bacteria
Organization type(s) Public Company
Funding types Shareholder Investment
Known funding amount 86,000,000 CHF
Country of production USA
Country of distribution USA + Switzerland
Trading symbol EVE
Trading exchange SWX
Notes Sold to Emergent BioSolutions in 2014
Added 2 years ago
Last modified 2 years ago